Federico
Martinón Torres
Hospital Clinic Barcelona
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (10)
2023
-
Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))
eBioMedicine
-
Dissecting the genetic heterogeneity of gastric cancer
eBioMedicine, Vol. 92
-
Prioritising respiratory syncytial virus prevention in low-income and middle-income countries
The Lancet Global Health
2022
2021
-
A Novel Framework for Phenotyping Children With Suspected or Confirmed Infection for Future Biomarker Studies
Frontiers in Pediatrics, Vol. 9
2017
-
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: Update based on the clinical evidence in Spain
BMC Infectious Diseases, Vol. 17, Núm. 1
2014
-
Erratun :Prevention of serogroup B meningococcal disease using a four-component vaccine (Anales de Pediatria (2014) 80 (259e1-259e23) DOI: 10.1016/j.anpedi.2013.04.013)
Anales de Pediatria
-
Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels
BMC Infectious Diseases, Vol. 14, Núm. 1
-
Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de cuatro componentes
Pediatria de Atencion Primaria, Vol. 16, Núm. 62
-
Prevention of serogroup B meningococcal disease using a four-component vaccin
Anales de Pediatria, Vol. 80, Núm. 4